Insights

Expansion in Personal Care SEQENS actively invests in the personal care sector, as evidenced by recent product launches such as AdvensProtect 2-EHG Green and Caprylyl Glycol, along with participation in major trade events like PCHI Guangzhou. This focus indicates opportunities to collaborate on eco-friendly and biobased cosmetic ingredients.

Strategic Asset Sales The sale of Botanical Actives and IVD activities to Solabia suggests a strategic shift towards consolidating core competencies in pharmaceutical and specialty ingredients, opening avenues for targeted partnerships in high-value active pharmaceutical ingredients and niche markets.

Innovation and R&D Focus With 300 scientists and multiple R&D centers across Europe, North America, and Asia, SEQENS demonstrates a strong commitment to innovation, presenting potential for customized ingredient solutions and advanced manufacturing collaborations with clients seeking cutting-edge pharmaceutical solutions.

Industry Collaborations Partnerships like the exclusive manufacturing agreement with Aether Industries highlight SEQENS' openness to strategic collaborations in bio-based products, indicating opportunities to introduce new sustainable raw materials and innovative biochemicals to prospective clients.

Global Manufacturing Footprint Operating 15 manufacturing sites across three continents allows SEQENS to offer reliable, localized supply chains for pharmaceutical and specialty ingredients, making it an attractive partner for companies seeking global scale with regional agility.

SEQENS Tech Stack

SEQENS uses 8 technology products and services including EIA, D2L Brightspace, Data Version Control, and more. Explore SEQENS's tech stack below.

  • EIA
    Advanced Analytics And Data Science
  • D2L Brightspace
    Communication And Collaboration
  • Data Version Control
    Development
  • Nacelle
    E-commerce
  • ADP Workforce Now
    Human Capital Management
  • Microsoft
    Miscellaneous
  • SpendMap
    Sales
  • Yoast SEO
    Search Engines

Media & News

SEQENS's Email Address Formats

SEQENS uses at least 1 format(s):
SEQENS Email FormatsExamplePercentage
First.Last@seqens.comJohn.Doe@seqens.com
89%
FLast@seqens.comJDoe@seqens.com
10%
First.L@seqens.comJohn.D@seqens.com
1%

Frequently Asked Questions

Where is SEQENS's headquarters located?

Minus sign iconPlus sign icon
SEQENS's main headquarters is located at 21 Chemin de la Sauvegarde Écully, Auvergne-rhône-alpes 69130 France. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is SEQENS's official website and social media links?

Minus sign iconPlus sign icon
SEQENS's official website is seqens.com and has social profiles on LinkedInCrunchbase.

What is SEQENS's NAICS code?

Minus sign iconPlus sign icon
SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

Minus sign iconPlus sign icon
As of March 2026, SEQENS has approximately 1.3K employees across 4 continents, including EuropeAsiaNorth America. Key team members include Ceo Wavelength Pharmaceuticals, General Manager Seqens Israel: I. A.Ceo: P. C.Chief Procurement Officer: C. D.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

Minus sign iconPlus sign icon
SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

Minus sign iconPlus sign icon
SEQENS's tech stack includes EIAD2L BrightspaceData Version ControlNacelleADP Workforce NowMicrosoftSpendMapYoast SEO.

What is SEQENS's email format?

Minus sign iconPlus sign icon
SEQENS's email format typically follows the pattern of First.Last@seqens.com. Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

Minus sign iconPlus sign icon
SEQENS was founded in 2003.

SEQENS

Pharmaceutical ManufacturingAuvergne-rhône-alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group operates 15 manufacturing sites and 5 R&D centers in Europe, North America and Asia. 2,700 employees contribute to the success of SEQENS, among which 300 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Section iconCompany Overview

Headquarters
21 Chemin de la Sauvegarde Écully, Auvergne-rhône-alpes 69130 France
Website
seqens.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
1001-5000

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    SEQENS's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.